Alfredo Molteni

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study

Francesco Passamonti, Chiara Cattaneo, Luca Arcaini et al. · The Lancet Haematology · 2020 · 551 citations · Full text

Mucormycosis in hematologic malignancies: an emerging fungal infection.

A. Nosari, Pierluigi Oreste, Marco Montillo et al. · PubMed · 2000 · 164 citations

Eltrombopag versus placebo for low-risk myelodysplastic syndromes with thrombocytopenia (EQoL-MDS): phase 1 results of a single-blind, randomised, controlled, phase 2 superiority trial

Esther Natalie Olíva, Caterina Alati, Valeria Santini et al. · The Lancet Haematology · 2017 · 159 citations · Full text

Eltrombopag Versus Placebo, Thrombosis, Thrombopoiesis +7

Prevalence of HCV infection in nongastric marginal zone B-cell lymphoma of MALT

Luca Arcaini, S. Burcheri, Andrea Rossi et al. · Annals of Oncology · 2006 · 145 citations · Full text

Lymphoid Neoplasia, Hcv Infection, Viral Hepatitis +5

A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis

Margherita Maffioli, Barbara Mora, Somedeb Ball et al. · Blood Advances · 2022 · 108 citations · Full text